Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 IKCS: Europe
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)
Home
Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)
Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)
Type here to filter the list
29: Efficacity and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: a retrospective multicentric study
Favorite
30: Association of ABO blood type with toxicity and response to immunotherapy in metastatic renal cell carcinoma (mRCC)
Favorite
31: Efficacy of immune checkpoint inhibitor (ICI) combination therapy as first-line (1L) treatment in metastatic renal cell carcinoma (mRCC).
Favorite
